Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2021-12-16 00:00:00 ET · period of report 2021-12-14 · accession 0001104659-21-150609 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-16 | 2021-12-14 | HRMY | ARONIN JEFFREY S | Dir | M - OptEx | $24.00 | +251.9K | 251.9K | New | +$6.05M |
| D | 2021-12-16 | 2021-12-14 | HRMY | ARONIN JEFFREY S | Dir | M - OptEx | $0.00 | +251.9K | 1.01M | +33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-14 | M | A | 251,922 | $24.00 | 251,922 | D | — | — | |
| 2 | Derivative | Stock Option | 2021-12-14 | M | A | 251,922 | $0.00 | 1,007,689 | D | $24.00 · — to 2030-08-18 | 251,922 Common Stock | (F1) The stock option shall vest in four equal annual installments beginning on August 21, 2022. |